AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’
AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies,…
BIO Releases New Report Underscoring the Massive Economic Power of the American Bioeconomy
Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm…
Federal government announces support for cutting-edge, AI- and robotics-enabled cell and gene therapy manufacturing
OmniaBio’s expanded facility in Hamilton seeks to drive a 5X increase in manufacturing efficiency while reducing produ…
European Medicines Agency recommends ‘landmark’ gene therapy for epidermolysis bullosa
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek…
Map, join and drive European activities for Advanced therapy medicinal product development and implementation for patient ans society benefit: JOIN4ATMP
JOIN4ATMPOvercoming hurdles in advanced therapy medicines Date: 1 January 2024 – 31 December 2026 (Ongoing) Coordi…
Stipulations of cell and gene therapy and the ties to biomanufacturing
Abstract Cell and gene therapy (CGT) products are emerging and innovative biopharmaceuticals that hold promise for treat…
Navigating Regulatory Frameworks and Compliances for Bacteriophages as Therapeutic Agents.
This review highlights the importance of regulatory standards in different stages of phage therapy- during preclinical r…
Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
Cell BioEngines, a clinical-stage biotechnology company developing a universal ‘plug-and-play’ allogeneic stem cell …
Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology
Astraveus SAS, the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR…
Neogap Therapeutics receives EMA’s ATMP classification for its personalised cancer cell therapy
Neogap Therapeutics AB, a Swedish clinical-stage biotechnology company, announces that the European Medicines Agency (EM…
Gene therapy reverses heart failure in new trials
Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy. New…
Synthetic Biology Focused Insights Report 2024-2029 with Competitive Analysis of 38 Vendors
The global synthetic biology market report contains exclusive data on 38 vendors. The market is highly competitive, with…